Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Clinical trial NCT01629966 · COMPLETED

Trial details

NCT number: NCT01629966
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2012-06-30
Primary completion: 2014-02-28
Enrollment: 680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.